Royal London Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,278
| Closed | -$343K | – | 725 |
|
|
2025
Q1 | $343K | Sell |
2,278
-14,147
| -86% | -$2.13M | ﹤0.01% | 708 |
|
|
2024
Q4 | $3.03M | Buy |
16,425
+991
| +6% | +$183K | 0.01% | 583 |
|
|
2024
Q3 | $3.04M | Sell |
15,434
-33
| -0.2% | -$6.5K | 0.01% | 588 |
|
|
2024
Q2 | $3.2M | Hold |
15,467
| – | – | 0.01% | 589 |
|
|
2024
Q1 | $4.19M | Sell |
15,467
-440
| -3% | -$119K | 0.01% | 573 |
|
|
2023
Q4 | $3.76M | Sell |
15,907
-305
| -2% | -$72.1K | 0.01% | 582 |
|
|
2023
Q3 | $3.18M | Hold |
16,212
| – | – | 0.01% | 595 |
|
|
2023
Q2 | $3.41M | Hold |
16,212
| – | – | 0.01% | 576 |
|
|
2023
Q1 | $3.27M | Sell |
16,212
-341
| -2% | -$68.8K | 0.01% | 559 |
|
|
2022
Q4 | $3.6M | Hold |
16,553
| – | – | 0.02% | 531 |
|
|
2022
Q3 | $3.26M | Sell |
16,553
-1,153
| -7% | -$227K | 0.02% | 538 |
|
|
2022
Q2 | $3.79M | Buy |
17,706
+616
| +4% | +$132K | 0.02% | 521 |
|
|
2022
Q1 | $4.85M | Buy |
17,090
+4,784
| +39% | +$1.36M | 0.02% | 508 |
|
|
2021
Q4 | $4.64M | Buy |
12,306
+8,958
| +268% | +$3.38M | 0.02% | 512 |
|
|
2021
Q3 | $1.38M | Buy |
+3,348
| New | +$1.38M | 0.01% | 635 |
|